Neurofibromatosis Type 1: Modeling CNS Dysfunction

被引:62
作者
Gutmann, David H. [1 ]
Parada, Luis F. [2 ]
Silva, Alcino J. [3 ]
Ratner, Nancy [4 ]
机构
[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
[2] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[3] Univ Calif Los Angeles, Los Angeles, CA 90095 USA
[4] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
基金
美国国家卫生研究院;
关键词
CORPUS-CALLOSUM MORPHOLOGY; MOUSE MODEL; PROGENITOR PROLIFERATION; GLIOMA FORMATION; ABERRANT GROWTH; NF1; GENE; BRAIN; CHILDREN; PATHWAY; DIFFERENTIATION;
D O I
10.1523/JNEUROSCI.3242-12.2012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Neurofibromatosis type 1 (NF1) is the most common monogenic disorder in which individuals manifest CNS abnormalities. Affected individuals develop glial neoplasms (optic gliomas, malignant astrocytomas) and neuronal dysfunction (learning disabilities, attention deficits). Nf1 genetically engineered mouse models have revealed the molecular and cellular underpinnings of gliomagenesis, attention deficit, and learning problems with relevance to basic neurobiology. Using NF1 as a model system, these studies have revealed critical roles for the NF1 gene in non-neoplastic cells in the tumor microenvironment, the importance of brain region heterogeneity, novel mechanisms of glial growth regulation, the neurochemical bases for attention deficit and learning abnormalities, and new insights into neural stem cell function. Here we review recent studies, presented at a symposium at the 2012 Society for Neuroscience annual meeting, that highlight unexpected cell biology insights into RAS and cAMP pathway effects on neural progenitor signaling, neuronal function, and oligodendrocyte lineage differentiation.
引用
收藏
页码:14087 / 14093
页数:7
相关论文
共 88 条
[1]   Lovastatin as Treatment for Neurocognitive Deficits Type 1: Phase I Study [J].
Acosta, Maria T. ;
Kardel, Peter G. ;
Walsh, Karin S. ;
Rosenbaum, Kenneth N. ;
Gioia, Gerard A. ;
Packer, Roger J. .
PEDIATRIC NEUROLOGY, 2011, 45 (04) :241-245
[2]   Neurofibromatosis type 1: Diffusion weighted imaging findings of brain [J].
Alkan, A ;
Sigirci, A ;
Kutlu, R ;
Ozcan, H ;
Erdem, G ;
Aslan, M ;
Ates, O ;
Yakinci, C ;
Egri, M .
EUROPEAN JOURNAL OF RADIOLOGY, 2005, 56 (02) :229-234
[3]   Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation [J].
Bajenaru, ML ;
Zhu, Y ;
Hedrick, NM ;
Donahoe, J ;
Parada, LF ;
Gutmann, DH .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (14) :5100-5113
[4]  
Bajenaru ML, 2003, CANCER RES, V63, P8573
[5]   ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS [J].
BASU, TN ;
GUTMANN, DH ;
FLETCHER, JA ;
GLOVER, TW ;
COLLINS, FS ;
DOWNWARD, J .
NATURE, 1992, 356 (6371) :713-715
[6]   Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants [J].
Bennett, MR ;
Rizvi, TA ;
Karyala, S ;
McKinnon, RD ;
Ratner, N .
JOURNAL OF NEUROSCIENCE, 2003, 23 (18) :7207-7217
[7]   Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells [J].
Bollag, G ;
Clapp, DW ;
Shih, S ;
Adler, F ;
Zhang, YY ;
Thompson, P ;
Lange, BJ ;
Freedman, MH ;
McCormick, F ;
Jacks, T ;
Shannon, K .
NATURE GENETICS, 1996, 12 (02) :144-148
[8]   Neurofibromatosis-1 heterozygosity impairs CNS neuronal morphology in a cAMP/PKA/ROCK-dependent manner [J].
Brown, Jacquelyn A. ;
Diggs-Andrews, Kelly A. ;
Gianino, Scott M. ;
Gutmann, David H. .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2012, 49 (01) :13-22
[9]   PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice [J].
Brown, Jacquelyn A. ;
Xu, Jinbin ;
Diggs-Andrews, Kelly A. ;
Wozniak, David F. ;
Mach, Robert H. ;
Gutmann, David H. .
EXPERIMENTAL NEUROLOGY, 2011, 232 (02) :333-338
[10]   Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice [J].
Brown, Jacquelyn A. ;
Emnett, Ryan J. ;
White, Crystal R. ;
Yuede, Carla M. ;
Conyers, Sara B. ;
O'Malley, Karen L. ;
Wozniak, David F. ;
Gutmann, David H. .
HUMAN MOLECULAR GENETICS, 2010, 19 (22) :4515-4528